Authors: Blyth, K Terry, A Mackay, N Vaillant, F Bell, M Cameron, ER Neil, JC Stewart, M

Citation: K. Blyth et al., Runx2: A novel oncogenic effector revealed by in vivo complementation and retroviral tagging, ONCOGENE, 20(3), 2001, pp. 295-302

Authors: Baxter, EW Blyth, K Cameron, ER Neil, JC

Citation: Ew. Baxter et al., Selection for loss of p53 function in T-cell lymphomagenesis is alleviatedby Moloney murine leukemia virus infection in myc transgenic mice, J VIROLOGY, 75(20), 2001, pp. 9790-9798

Authors: Cameron, ER Morton, J Johnston, CJ Irvine, J Bell, M Onions, DE Neil, JC Campbell, M Blyth, K

Citation: Er. Cameron et al., Fas-independent apoptosis in T-cell tumours induced by the CD2-myc transgene, CELL DEAT D, 7(1), 2000, pp. 80-88

Authors: Blyth, K Stewart, M Bell, M James, C Evan, G Neil, JC Cameron, ER

Citation: K. Blyth et al., Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycER (TM) mice, ONCOGENE, 19(6), 2000, pp. 773-782

Authors: Vaillant, F Blyth, K Terry, A Bell, M Cameron, ER Neil, J Stewart, M

Citation: F. Vaillant et al., A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with MYC, ONCOGENE, 18(50), 1999, pp. 7124-7134

Authors: Neil, J Stewart, M Terry, A O'Hara, M Hu, M Blyth, K Baxter, E Onions, D Cameron, E

Citation: J. Neil et al., Identification of murine CBF alpha 1, a runt domain transcription factor, as a putative Myc collaborator in T cell lymphoma, LEUKEMIA, 13, 1999, pp. S83-S86